A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice
NCT ID: NCT02740218
Last Updated: 2024-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
610 participants
OBSERVATIONAL
2016-06-30
2021-10-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.
NCT01232283
A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy
NCT03930186
A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life
NCT03774875
A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp
NCT03123471
Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
NCT01194219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Psoriasis patients
Single cohort of psoriasis patients treated with OTEZLA (apremilast)
Patient questionnaire
Patients will be asked to complete a questionnaire regarding their expectations, experience and satisfaction in taking OTEZLA (apremilast) treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient questionnaire
Patients will be asked to complete a questionnaire regarding their expectations, experience and satisfaction in taking OTEZLA (apremilast) treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age ≥ 18 years at the time of signing the ICF.
3. Diagnosed with plaque psoriasis.
4. Initiated treatment with apremilast 6 months (+/- 1 month) previously (patients may or may not have completed 6 months of apremilast treatment)
Exclusion Criteria
2. Started apremilast as part of a clinical trial.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amgen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MD
Role: STUDY_DIRECTOR
Amgen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medizinische Universität Graz
Graz, , Austria
Praxis Dr. Wolfgang Fuchs
Grosswarasdorf, , Austria
Praxis Dr. Schicher
Klagenfurt, , Austria
Praxis Dr. Wilhelm
Landeck, , Austria
Kepler Universitätsklinikum
Linz, , Austria
Praxis Dr. Dunst-Huemer
Linz, , Austria
Krankenanstalt Rudolfstiftung
Vienna, , Austria
Medizinische Universität Wien
Vienna, , Austria
Praxis Dr. Göttfried
Vienna, , Austria
Praxis Dr. Holub-Hoberger
Vienna, , Austria
Krankenhaus Hietzing
Vienna, , Austria
Praxis Dr. Nordberg
Vienna, , Austria
Praxis Dr. Menzinger
Vienna, , Austria
Praxis Dr. Sator
Vienna, , Austria
Praxis Dr. Perl-Convalexius
Vienna, , Austria
Klinikum Wels-Grieskirchen GmbH
Wels, , Austria
Landesklinikum Wiener Neustadt
Wiener Neustadt, , Austria
Klinički bolnički centar Osijek Zavod za dermatologiju i venerologiju
Osijek, , Croatia
Klinički bolnički centar Rijeka Klinika za dermatovenerologiju
Rijeka, , Croatia
Klinički bolnički centar Split Klinika za kožne i spolne bolesti
Split, , Croatia
Klinički bolnički centar Sestre milosrdnice Klinika za kožne i spolne bolest
Zagreb, , Croatia
Klinički bolnički centar Zagreb Klinika za dermatovenerologiju
Zagreb, , Croatia
Fakultní nemocnice Hradec Králové Klinika nemocí kožních a pohlavních
Hradec Králové, Novy Hradec Králové, Czechia
Nemocnice Pardubického kraje
Pardubice, Pardubice IV, Czechia
Sanatorium profesora Arenberger
Prague, Praha 1, Czechia
Všeobecná fakultní nemocnice v Praze
Prague, Praha 2, Czechia
Fakultní nemocnice v Motole
Prague, Praha 5, Czechia
Nemocnice Jihlava příspěvková organizace
Jihlava, , Czechia
FN Plzen Bory Dermatovenerologické oddělení
Pilsen, , Czechia
Company for Medical Study & Service
Selters, Westerwald, Germany
Praxis Dr. Harst
Aachen, , Germany
Praxis Dr. Wagner-Schiffler
Aachen, , Germany
Praxis Dr. Dietz
Ampfing, , Germany
Praxis Dr. Bell
Andernach, , Germany
Licca Clinical Research Institute
Augsburg, , Germany
Gefäß- und Hautzentrum Blaustein
Blaustein, , Germany
St. Josef und St. Elisabeth Hospital gGmbH
Bochum, , Germany
Rheinische Friedrich-Wilhelms-Universität Bonn
Bonn, , Germany
Praxis Dr. Jordan
Brühl, , Germany
Elbe Klinikum Buxtehude
Buxtehude, , Germany
Praxis Dr. Schneider
Dachau, , Germany
Praxis Dr. Thelen
Delmenhorst, , Germany
Klinikum Dortmund
Dortmund, , Germany
Praxis Dr. Scheibner
Dresden, , Germany
Praxis Dr. Korge
Düren, , Germany
Praxis für Dermatologie und Venerologie, Allergologie
Eltville, , Germany
Praxis Dr. Schurhammer-Fuhrmann
Endingen, , Germany
Uniklinikum Erlangen
Erlangen, , Germany
Praxis Dr. Huerkamp
Euskirchen, , Germany
Praxis Dr. Swirski
Euskirchen, , Germany
Universitätsklinikum Frankfurt
Frankfurt, , Germany
Praxis Dr. Kämmerer
Freiberg, , Germany
Praxis Dr. Kurzen
Freising, , Germany
GP Dr. Rotterdam & Kollegen
Gelsenkirchen, , Germany
Praxis Dr. med W. Klövekorn, Dr. med. A. Tepe, Dr. med. O. Wilde
Gilching, , Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, , Germany
Praxis Dr. Schmidt
Kusel, , Germany
Praxis Birgit Zimmermann
Malchow, , Germany
Praxis Dr. Piontek
Mechernich, , Germany
Dermatologische Praxis Dr. med. Schwinn
Memmingen, , Germany
Praxis Büchler
Memmingen, , Germany
Praxis Dr. Antal
Mühldorf, , Germany
Praxis Dr. Cords
Mühlheim, , Germany
Praxis Dr. Liebich
München, , Germany
Technische Universität München
München, , Germany
Universitätsklinikum Regensburg
Regensburg, , Germany
Praxis Dr. Prell
Rosenheim, , Germany
Praxis Dr. Blank
Rostock, , Germany
Praxis Dr. Hoene
Rostock, , Germany
Praxis Dr. Schenkelberger
Sankt Ingbert, , Germany
Praxis Dr. Neisius
Stolberg, , Germany
Praxis Dr. Steinborn
Straubing, , Germany
Universitätsklinikum Tübingen
Tübingen, , Germany
Gemeinschaftspraxis Dr. Christian Fischer, Florian Kreuziger
Vilshofen, , Germany
Praxis Dr. Dehmel
Wasserburg am Inn, , Germany
Praxis Dr. Schmeel
Wesseling, , Germany
Praxis Dr. Buttgereit
Wildau, , Germany
Praxis Dr. Süß
Wittlich, , Germany
Bon Secours Hospital
Tralee, County Kerry, Ireland
Mater Misericordiae University Hospital
Dublin, , Ireland
University Hospital Galway
Galway, , Ireland
Uniiverzitetni klinični center Maribor Oddelek za kožne in spolne bolezni
Maribor, , Slovenia
Hospital Fundacion Alcorcon, Madrid
Alcorcón, Madrid, Spain
Vithas Xanit Iinternational Hospital
Benalmádena, , Spain
Hospital Universitario San Cecilio (PTS)
Granada, , Spain
Hospital Virgen de la Victoria
Málaga, , Spain
Hudkliniken Mälarsjukhuset
Eskilstuna, , Sweden
Hudkliniken SU/ Sahlgrenska
Gothenburg, , Sweden
Hudmottagningen Karlskoga Lasarett
Karlskoga, , Sweden
Hudmottagningen Lindesbergs Lasarett
Lindesberg, , Sweden
Capio Citykliniken Lund
Lund, , Sweden
Diagnostiskt Centrum Hud Malmö
Malmo, , Sweden
SUS Malmö Hudkliniken
Malmo, , Sweden
Hudkliniken Vrinnevisjukhuset Norrköping
Norrköping, , Sweden
Diagnostiskt Centrum Hud Stockholm
Stockholm, , Sweden
Cutisgruppen/Stockholm Hud
Stockholm, , Sweden
Hudkliniken SÖS
Stockholm, , Sweden
Hudcentrum Hagastaden
Stockholm, , Sweden
Karolinska Psoriasis Center
Stockholm, , Sweden
Hudkliniken Danderyds Sjukhus
Stockholm, , Sweden
Hudmottagningen Trelleborg
Trelleborg, , Sweden
Hudmottagningen Västervik
Västervik, , Sweden
Dermatologie Aesche
Basel, , Switzerland
Somamedica
Basel, , Switzerland
Ospedale Bellinzona e Valli EOC
Bellinzona, , Switzerland
Insel Gruppe AG
Bern, , Switzerland
Clinique dermatologie du Seujet
Geneva, , Switzerland
Hautarzt Oberaargau AG
Herzogenbuchsee, , Switzerland
Centre hospitalier universitaire Vaudois (CHUV)
Lausanne, , Switzerland
Studio medico Dr. Pelloni
Lugano, , Switzerland
Practice Dr. Niklaus
Martigny-Ville, , Switzerland
Pallas Klinik Olten
Olten, , Switzerland
Haut und Laserzentrum Dr. Zuder
Sankt Gallen, , Switzerland
Praxis Dr. med. Christian Schuster
Sankt Gallen, , Switzerland
Haut und Allergiezentrum Brunnehof
Uster, , Switzerland
Dr. Tomi Haut- und Laserzentrum
Weinfelden, , Switzerland
Hautpraxis Dermateam
Winterthur, , Switzerland
Praxisgemeinschaft Bünz AG
Wohlen, , Switzerland
Zug Hautarzt
Zug, , Switzerland
Universitätsspital Zürich
Zurich, , Switzerland
Aberdeen Royal Infirmary
Aberdeen, , United Kingdom
Bradford Teaching Hospitals NHS
Bradford, , United Kingdom
West Suffolk NHS Foundation
Bury St Edmunds, , United Kingdom
East Kent & Canterbury Hospital
Canterbury, , United Kingdom
NHS Dumfries and Galloway
Dumfries, , United Kingdom
Royal Devon & Exeter NHS Foundation Trust
Exeter, , United Kingdom
West Middlesex University Hospital
Isleworth, , United Kingdom
Chapel Allerton Hospital
Leeds, , United Kingdom
Guy's and St Thomas's NHS Foundation Trust
London, , United Kingdom
Chelsea & Westminster NHS Foundation Trust
London, , United Kingdom
Royal Victoria Infirmary
Newcastle upon Tyne, , United Kingdom
University of Manchester
Salford, , United Kingdom
Warwick Hospital
Warwick, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pedro Herranza, Lidia Trasobaresb, Almudena Mateuc, Esperanza Martínezd, Ricardo Ruiz-Villaverdee, Ofelia Baniandrésf, Javier Mataixg, Natalia Jiménez-Gómezh, Marta Serrai, Diana Patricia Ruiz Genaoj, Noelia Riverak, Jesús Tercedor-Sánchezl, Carmen Garciam, Myriam Cordeyn, Enrique Herrera-Acostao. Characterization and outcomes of patients treated with apremilast in the Spanish routine clinical practice: Results from the APPRECIATE study. Actas Dermosifiliogr.
Cetkovska P, Dediol I, Sola M, Kojanova M, Trcko K, Carija A, Ceovic R, Ledic-Drvar D, Kastelan M, Hrabar A, Missoup MC, Mamun K. Apremilast Use in Severe Psoriasis: Real-World Data from Central and Eastern Europe. Adv Ther. 2023 Apr;40(4):1787-1802. doi: 10.1007/s12325-023-02468-3. Epub 2023 Mar 2.
da Silva Burger N, Tran KV, Typou M, Sommer R, Neasham D, Cordey M, Augustin M. Benefits and Satisfaction with Apremilast Treatment in Patients with Psoriasis Affecting the Genital Area: Secondary Analysis of the APPRECIATE Study. Dermatol Ther (Heidelb). 2025 Mar;15(3):681-695. doi: 10.1007/s13555-025-01360-y. Epub 2025 Feb 19.
Jonak C, Gottfried I, Perl-Convalexius S, Gruber B, Schutz-Bergmayr M, Vujic I, Weger W, Schicher N, Semlin L, Hemetsberger M, Cordey M, Sator P. Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria - results the APPRECIATE study. Ther Adv Chronic Dis. 2023 Feb 7;14:20406223231152785. doi: 10.1177/20406223231152785. eCollection 2023.
Related Links
Access external resources that provide additional context or updates about the study.
AmgenTrials clinical trials website
Expanded Access for CC-10004
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CC-10004-PSOR-013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.